Trademarkia Logo

Canada

C$
MINJUVI
REGISTERED

on 21 Jun 2023

Last Applicant/ Owned by

INCYTE HOLDINGS CORPORATION

1801 Augustine Cut-OffWilmington DE 19803

US

Serial Number

2067066 filed on 19th Oct 2020

Registration Number

TMA1185964 registered on 21st Jun 2023

Registration expiry Date

19th Oct 2030

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

MINJUVI

Trademark usage description

pharmaceuticals and pharmaceutical preparations for human for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, diab Read More

Classification Information


Class [005]
Pharmaceuticals and pharmaceutical preparations for human for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, chronic obstructive pulmonary disease, inflammatory diseases of the thyroid, pelvic inflammatory disease, arthritis, asthma; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical diagnostic use; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases of the thyroid and pelvic region, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents for medical use; biological preparations for medical purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis.


Classification kind code

11

Class [042]
Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research and medical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies.


Classification kind code

11

Mark Details


Serial Number

2067066

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 18th Mar 2022
Agent Changed
Submitted for opposition 256
on 27th Sept 2021
Notification of Possible Opposition Sent
Submitted for opposition 22
on 16th Jun 2021
Search Recorded
Submitted for opposition 20
on 16th Jun 2021
Examiner's First Report
Submitted for opposition 223
on 16th Jun 2021
Total Provisional Refusal
Submitted for opposition 31
on 30th Nov 2020
Formalized
Submitted for opposition 1
on 30th Nov 2020
Created
Submitted for opposition 257
on 26th Nov 2020
Designation Notification - Madrid Protocol
Submitted for opposition 228
on 19th Oct 2020
International Registration
Submitted for opposition 30
on 19th Oct 2020
Filed